Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Reneo Pharmaceuticals, Inc. RPHM

Full chart Compare
Set alert

Price alert · RPHM

All alert types
18.20 +18.20

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

1.84 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -4.1×
FY 2019: -93.8×FY 2020: -188×FY 2021: -39.0×FY 2022: -11.4×FY 2023: -7.0×FY 2024: 0.0×FY 2025: -4.1×
FY 2019 5y median -7.0× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 4.4×
FY 2019: -50.5×FY 2020: -86.2×FY 2021: 10.5×FY 2022: 5.7×FY 2023: 6.1×FY 2024: 6.0×FY 2025: 4.4×
FY 2019 5y median 6.0× FY 2025
P/FCF -4.7×
FY 2019: -93.3×FY 2020: -196×FY 2021: -40.6×FY 2022: -12.0×FY 2023: -8.4×FY 2024: -12.3×FY 2025: -4.7×
FY 2019 5y median -12.0× FY 2025
EV/EBITDA -3.0×
FY 2019: -77.5×FY 2020: -188×FY 2021: -35.9×FY 2022: -10.3×FY 2023: -6.2×FY 2024: 782×FY 2025: -3.0×
FY 2019 5y median -6.2× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -21.1%
FY 2019: -1.1%FY 2020: -0.5%FY 2021: -2.5%FY 2022: -8.4%FY 2023: -11.9%FY 2024: -8.2%FY 2025: -21.1%
FY 2019 5y median -8.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 0.0%
FY 2019: 53.8%FY 2020: 46.2%FY 2021: -27.0%FY 2022: -50.1%FY 2023: -87.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median -27.0% FY 2025
ROIC 0.0%
FY 2019: -68.6%FY 2020: -38.6%FY 2021: -26.9%FY 2022: -53.1%FY 2023: -92.7%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median -26.9% FY 2025
ROA 0.0%
FY 2019: -48.8%FY 2020: -35.2%FY 2021: -25.8%FY 2022: -46.3%FY 2023: -72.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median -25.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -15.7%
FY 2019: 0.0%FY 2020: -26.4%FY 2021: -103.7%FY 2022: -35.2%FY 2023: -54.2%FY 2024: 34.5%FY 2025: -15.7%
FY 2019 FY 2025
EPS (diluted) 0.0%
FY 2019: 0.0%FY 2020: 50.0%FY 2021: -173.7%FY 2022: 6.8%FY 2023: -12.7%FY 2024: 100.0%FY 2025: 0.0%
FY 2019 FY 2025
Free Cash Flow -1.4%
FY 2019: 0.0%FY 2020: -48.3%FY 2021: -105.7%FY 2022: -25.0%FY 2023: -33.9%FY 2024: 19.9%FY 2025: -1.4%
FY 2019 FY 2025

Financial Health

Current Ratio 10.3×
FY 2019: 8.6×FY 2020: 12.0×FY 2021: 24.8×FY 2022: 14.9×FY 2023: 5.9×FY 2024: 10.7×FY 2025: 10.3×
FY 2019 5y median 10.7× FY 2025
Quick Ratio 10.3×
FY 2019: 8.6×FY 2020: 12.0×FY 2021: 24.8×FY 2022: 14.9×FY 2023: 5.9×FY 2024: 10.7×FY 2025: 10.3×
FY 2019 5y median 10.7× FY 2025
Debt / Equity 0.0×
FY 2019: -2.0×FY 2020: -2.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2019: -1.8×FY 2020: -2.0×FY 2021: 3.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: -166×FY 2025: 0.9×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 7869×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 181×FY 2025: 7869×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31